GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Revenio Group Oyj (STU:R0V) » Definitions » Revenue

Revenio Group Oyj (STU:R0V) Revenue : €97.08 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Revenio Group Oyj Revenue?

Revenio Group Oyj's revenue for the three months ended in Mar. 2024 was €23.60 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €97.08 Mil. Revenio Group Oyj's Revenue per Share for the three months ended in Mar. 2024 was €0.90. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €3.66.

Warning Sign:

Revenio Group Oyj revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Revenio Group Oyj was -3.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 16.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 23.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 22.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Revenio Group Oyj's highest 3-Year average Revenue per Share Growth Rate was 32.30% per year. The lowest was -34.80% per year. And the median was 14.70% per year.


Revenio Group Oyj Revenue Historical Data

The historical data trend for Revenio Group Oyj's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revenio Group Oyj Revenue Chart

Revenio Group Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.47 61.07 78.78 96.98 96.58

Revenio Group Oyj Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.20 22.30 22.00 29.18 23.60

Competitive Comparison of Revenio Group Oyj's Revenue

For the Medical Devices subindustry, Revenio Group Oyj's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revenio Group Oyj's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's Revenue distribution charts can be found below:

* The bar in red indicates where Revenio Group Oyj's Revenue falls into.



Revenio Group Oyj Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €97.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Revenio Group Oyj  (STU:R0V) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Revenio Group Oyj Revenue Related Terms

Thank you for viewing the detailed overview of Revenio Group Oyj's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Revenio Group Oyj (STU:R0V) Business Description

Traded in Other Exchanges
Address
Ayritie 22, Vantaa, FIN, 01510
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.

Revenio Group Oyj (STU:R0V) Headlines

No Headlines